Home
1
News
2
最新消息
3
[2025/03] News- LYNTONIX has been approved as a High-Risk Innovative Starup by Industrial Development Administration (IDA), Ministry of Economic Affairs (MOEA), Taiwan4
https://www.lyntonix.com/en/ LYNTONIX, INC.
LYNTONIX, INC. 17, Xuzhou Road, Room 936, Taipei, 100 Taiwan
Lyntonix officially joined ITRI’s Biomedical Accelerator on Sep. 14, 2026. By leveraging the accelerator’s industry resources and professional networking platform, Lyntonix aims to further strengthen its connections with industry partners, prospective collaborators, and professionals across various areas of business operations, thereby creating broader opportunities for strategic collaboration and business development. https://www.lyntonix.com/en/hot_540088.html [2026/09] News-Lyntonix Joins ITRI’s Biomedical Accelerator to Strengthen Industry Partnerships and Expand Collaboration Opportunities 2026-10-05 2027-10-05
LYNTONIX, INC. 17, Xuzhou Road, Room 936, Taipei, 100 Taiwan https://www.lyntonix.com/en/hot_540088.html
LYNTONIX, INC. 17, Xuzhou Road, Room 936, Taipei, 100 Taiwan https://www.lyntonix.com/en/hot_540088.html
https://schema.org/EventMovedOnline https://schema.org/OfflineEventAttendanceMode
2026-10-05 http://schema.org/InStock TWD 0 https://www.lyntonix.com/en/hot_540088.html

According to Article 3, Paragraph 1 of “Regulations Governing the Identification of High-Risk Innovative Startups as Referred to in Article 12 of the Income Basic Tax Act”, LYNTONIX has been approved as a “High-Risk Innovative Startup”. Investments in LYNTONIX are therefore eligible for the Income Basic Tax credit.

Previous Back to List Next